Structures by: Khan I.
Total: 63
C9H11B1O3
C9H11B1O3
Organic Chemistry Frontiers (2019) 6, 11 1895
a=6.4968(13)Å b=22.260(5)Å c=7.1909(14)Å
α=90.00° β=116.20(3)° γ=90.00°
C21H20O5S
C21H20O5S
Organic letters (2013) 15, 3 570-573
a=8.1107(2)Å b=11.3209(3)Å c=11.3866(3)Å
α=108.914(2)° β=101.259(2)° γ=104.447(2)°
C18H13ClN2O4
C18H13ClN2O4
Crystals (2012) 2, 3 967-973
a=6.6491(3)Å b=7.9627(6)Å c=30.621(5)Å
α=90.00° β=90.00° γ=90.00°
C11H14O4
C11H14O4
Crystals (2012) 2, 2 521-527
a=8.5518(3)Å b=10.8826(8)Å c=11.9939(6)Å
α=101.273(5)° β=98.287(3)° γ=94.092(4)°
Aminonitroguanidinium bromide monohydrate
CH6N5O2,Br,H2O
Crystals (2012) 2, 2 675-689
a=8.0261(5)Å b=12.7412(7)Å c=7.9296(5)Å
α=90.00° β=118.051(9)° γ=90.00°
N-[2-trans-(4-hydroxyphenyl) ethenyl] formamide
C9H9NO2
RSC Advances (2020) 10, 35 20738-20744
a=12.9027(9)Å b=6.9592(4)Å c=18.0598(16)Å
α=90° β=90° γ=90°
Xanthocillin X
C2H6OS,C9H6NO
RSC Advances (2020) 10, 35 20738-20744
a=6.4707(3)Å b=6.4978(2)Å c=13.6439(5)Å
α=96.434(3)° β=102.426(4)° γ=94.819(3)°
C17H21NO7
C17H21NO7
Chemical communications (Cambridge, England) (2020) 56, 82 12431-12434
a=6.921(6)Å b=10.91(3)Å c=24.068(19)Å
α=90° β=90° γ=90°
C13H12O5
C13H12O5
Chemical communications (Cambridge, England) (2020) 56, 82 12431-12434
a=6.6885(3)Å b=7.1093(3)Å c=24.1880(9)Å
α=90° β=90° γ=90°
C27H29N7O2
C27H29N7O2
MedChemComm (2018) 9, 7 1213-1225
a=9.814(2)Å b=9.916(2)Å c=25.156(5)Å
α=90° β=90.477(4)° γ=90°
C20H14N2O5
C20H14N2O5
Chemical communications (Cambridge, England) (2018) 54, 37 4708-4711
a=6.6428(3)Å b=14.2542(6)Å c=17.8105(7)Å
α=90° β=90° γ=90°
C20H14N2O5
C20H14N2O5
Chemical communications (Cambridge, England) (2018) 54, 37 4708-4711
a=11.4782(3)Å b=14.6774(4)Å c=10.8540(3)Å
α=90° β=115.8240(10)° γ=90°
C21H19NO3
C21H19NO3
Chemical communications (Cambridge, England) (2018) 54, 37 4708-4711
a=7.0542(2)Å b=14.1154(4)Å c=17.6777(5)Å
α=90° β=90° γ=90°
Dichlorido-bis[N-(4-methoxyphenyl)acetamide-O]-zinc(II)
C18H22Cl2N2O4Zn
New J. Chem. (2016) 40, 8 7084
a=16.8955(6)Å b=10.3515(4)Å c=11.5475(5)Å
α=90° β=90° γ=90°
E)-N'-(biphenyl-4-ylmethylene)-2-(4-bromophenyl)acetohydrazide
C21H17BrN2O
RSC Advances (2015) 5, 110 90806
a=20.4423(11)Å b=5.5758(3)Å c=7.6350(7)Å
α=90° β=98.621(7)° γ=90°
C13H19Cl0NO4SZn0
C13H19Cl0NO4SZn0
RSC Advances (2015) 5, 38 30125
a=5.51320(10)Å b=11.8110(2)Å c=21.7712(3)Å
α=90.00° β=90.00° γ=90.00°
C13H21N3O3S
C13H21N3O3S
CrystEngComm (2019) 21, 11 1780
a=10.3216(9)Å b=6.6441(5)Å c=12.0540(11)Å
α=90° β=105.426(4)° γ=90°
C12H19N3O3S
C12H19N3O3S
CrystEngComm (2019) 21, 11 1780
a=7.6720(11)Å b=9.7977(13)Å c=9.9187(13)Å
α=90° β=90.011(5)° γ=90°
C11H16ClN3O3S
C11H16ClN3O3S
CrystEngComm (2019) 21, 11 1780
a=10.4296(6)Å b=6.7642(3)Å c=11.2829(6)Å
α=90° β=113.623(3)° γ=90°
C9H12ClN3O3S
C9H12ClN3O3S
CrystEngComm (2019) 21, 11 1780
a=10.0850(5)Å b=6.6661(3)Å c=18.9899(9)Å
α=90° β=104.813(3)° γ=90°
C25H26O2
C25H26O2
Chemical communications (Cambridge, England) (2015) 51, 13 2613-2616
a=12.4084(5)Å b=6.0932(2)Å c=26.1861(9)Å
α=90° β=96.043(3)° γ=90°
C24H23ClO2
C24H23ClO2
Chemical communications (Cambridge, England) (2015) 51, 13 2613-2616
a=12.4763(3)Å b=6.01195(15)Å c=26.1383(8)Å
α=90° β=97.180(3)° γ=90°
C26H20O
C26H20O
Chemical communications (Cambridge, England) (2015) 51, 13 2613-2616
a=9.3875(3)Å b=10.8930(4)Å c=18.5220(7)Å
α=90° β=95.417(3)° γ=90°
C28H25NO2
C28H25NO2
Chemical communications (Cambridge, England) (2015) 51, 13 2613-2616
a=9.89753(16)Å b=24.4163(4)Å c=9.00094(16)Å
α=90° β=93.3654(14)° γ=90°
(E)-N'-(2-(allyloxy)benzylidene)-2-(4-bromophenyl)acetohydrazide
C18H17BrN2O2
RSC Advances (2015) 5, 110 90806
a=14.6957(3)Å b=4.84494(11)Å c=23.1542(5)Å
α=90° β=102.219(2)° γ=90°
C12H19N3O4S
C12H19N3O4S
CrystEngComm (2019) 21, 11 1780
a=10.4333(7)Å b=6.8279(4)Å c=11.1774(7)Å
α=90° β=113.332(4)° γ=90°
5-(2,6-dichlorobenzyl)-1,3,4-oxadiazole-2(3H)-thione, dimethyl sulfoxide solvate
C9H6Cl2N2OS,C2H6OS
CrystEngComm (2017)
a=11.9557(4)Å b=13.5378(5)Å c=9.0424(3)Å
α=90° β=99.981(2)° γ=90°
C9H7ClN2OS
C9H7ClN2OS
CrystEngComm (2017)
a=12.7860(5)Å b=12.8784(5)Å c=13.3520(6)Å
α=90° β=116.878(2)° γ=90°
C9H7BrN2OS
C9H7BrN2OS
CrystEngComm (2017)
a=4.7154(4)Å b=11.7528(9)Å c=17.8887(16)Å
α=90° β=90.015(4)° γ=90°
C13H8ClN3O4S
C13H8ClN3O4S
Dalton transactions (Cambridge, England : 2003) (2013) 42, 13 4436-4449
a=7.9977(3)Å b=17.1647(6)Å c=9.7786(3)Å
α=90.00° β=94.152(2)° γ=90.00°
C15H10ClN3O4
C15H10ClN3O4
Dalton transactions (Cambridge, England : 2003) (2013) 42, 13 4436-4449
a=6.449(13)Å b=8.009(16)Å c=14.00(3)Å
α=77.16(3)° β=84.58(3)° γ=86.44(3)°
C9H8N3O5SV
C9H8N3O5SV
Dalton transactions (Cambridge, England : 2003) (2013) 42, 13 4436-4449
a=6.8143(5)Å b=6.8092(4)Å c=12.6802(9)Å
α=90.00° β=92.987(3)° γ=90.00°
C28H25Cl2FeN3O5Pt
C28H25Cl2FeN3O5Pt
Dalton transactions (Cambridge, England : 2003) (2014) 43, 2 751-763
a=10.903(5)Å b=11.447(5)Å c=11.741(5)Å
α=76.850(5)° β=76.038(5)° γ=85.057(5)°
C23H23Cl2FeN3O2Pt
C23H23Cl2FeN3O2Pt
Dalton transactions (Cambridge, England : 2003) (2014) 43, 2 751-763
a=8.4489(3)Å b=16.5732(6)Å c=18.2765(7)Å
α=68.997(2)° β=89.193(2)° γ=81.238(2)°
C33H27ClN2O7V
C33H27ClN2O7V
Chem.Commun. (2012) 48, 7702
a=9.3606(11)Å b=12.8152(18)Å c=16.3781(19)Å
α=102.249(11)° β=101.851(10)° γ=104.124(11)°
C17H13BrN4OS
C17H13BrN4OS
RSC Adv. (2015)
a=7.5733(3)Å b=10.0581(7)Å c=11.2828(6)Å
α=105.441(5)° β=102.930(4)° γ=91.660(4)°
5-(4-methoxybenzyl)-1,3,4-thiadiazole-2(3H)-thione
C10H10N2O2S
CrystEngComm (2014) 16, 2 164
a=7.5365(3)Å b=5.5019(3)Å c=24.9737(12)Å
α=90° β=92.956(2)° γ=90°
5-(2-methoxybenzyl)-1,3,4-thiadiazole-2(3H)-thione
C10H10N2O2S
CrystEngComm (2014) 16, 2 164
a=11.6420(9)Å b=4.6349(4)Å c=18.8292(18)Å
α=90.00° β=95.453(5)° γ=90.00°
5-(3-methoxybenzyl)-1,3,4-thiadiazole-2(3H)-thione
C10H10N2O2S
CrystEngComm (2014) 16, 2 164
a=8.6916(7)Å b=13.2144(11)Å c=8.9458(7)Å
α=90.00° β=93.960(4)° γ=90.00°
5-(2-methoxyphenethyl)-1,3,4-thiadiazole-2(3H)-thione
C11H12N2O2S
CrystEngComm (2014) 16, 2 164
a=9.8668(8)Å b=6.9888(6)Å c=16.1978(13)Å
α=90.00° β=98.855(4)° γ=90.00°
5-(4-methoxyphenethyl)-1,3,4-thiadiazole-2(3H)-thione
C11H12N2O2S
CrystEngComm (2014) 16, 2 164
a=7.8075(8)Å b=11.2905(13)Å c=13.2898(18)Å
α=88.359(7)° β=80.741(6)° γ=73.514(6)°
Dodecasodium acetato(arsenotungstato)triaquacarbonato(ditungstato)sodiumdiyttrium dodecahyrate
As2C3Na12O110W20Y2,3(O)
Acta Crystallographica Section C (2018) 74, 11 1355-1361
a=13.3054(4)Å b=18.0281(6)Å c=22.4544(5)Å
α=91.090(2)° β=92.169(2)° γ=108.155(3)°
Diyttrium tripotassium tetrasodium triaquacarbonato(germanotungstato)triyttrium nonadecahydrate
0.25(C4Ge8K12Na16O364W72Y20),4(O)
Acta Crystallographica Section C (2018) 74, 11 1355-1361
a=23.3948(6)Å b=24.5658(5)Å c=18.6887(5)Å
α=90° β=110.869(3)° γ=90°
Ytterbium octapotassiumdisodium triaquacarbonato(germanotungstato)triyttrium hexadecahydrate
0.25(C4Ge8K32Na4O372W72Yb16)
Acta Crystallographica Section C (2018) 74, 11 1355-1361
a=22.2367(6)Å b=22.6726(5)Å c=20.1786(5)Å
α=90° β=111.037(3)° γ=90°
2-Formylphenyl 4-methylbenzenesulfonate
C14H12O4S
Acta Crystallographica Section C (2018) 74, 7
a=23.7755(16)Å b=8.3718(5)Å c=16.3235(12)Å
α=90° β=124.106(3)° γ=90°
2-Formylphenyl 4-chlorobenzenesulfonate
C13H9ClO4S
Acta Crystallographica Section C (2018) 74, 7
a=13.7066(8)Å b=12.9371(8)Å c=7.4310(4)Å
α=90° β=91.565(3)° γ=90°
4-Formylphenyl 4-chlorobenzenesulfonate
C13H9ClO4S
Acta Crystallographica Section C (2018) 74, 7
a=10.4670(5)Å b=11.9547(5)Å c=10.6575(4)Å
α=90° β=98.0450(10)° γ=90°
2-Formylphenyl 4-bromobenzenesulfonate
C13H9BrO4S
Acta Crystallographica Section C (2018) 74, 7
a=7.8282(5)Å b=8.5963(6)Å c=10.1139(6)Å
α=91.249(3)° β=102.818(2)° γ=95.938(3)°
4-Formylphenyl 4-bromobenzenesulfonate
C13H9BrO4S
Acta Crystallographica Section C (2018) 74, 7
a=6.8248(3)Å b=7.2849(4)Å c=15.1587(9)Å
α=79.746(3)° β=83.570(2)° γ=65.091(2)°
2-(4-Chlorophenyl)-2-oxoethyl 3-bromobenzoate
C15H10BrClO3
Acta Crystallographica Section E (2014) 70, 11 301-304
a=6.6797(3)Å b=10.0238(4)Å c=10.7851(5)Å
α=90.980(4)° β=107.573(4)° γ=92.138(3)°
2,5-Dicarboethoxy-3,4-diphenylcyclopentadienone
C23H20O5
Acta Crystallographica Section E (2002) 58, 1 o8-o9
a=10.697(3)Å b=18.228(4)Å c=11.202(2)Å
α=90.00° β=115.02(2)° γ=90.00°
4-<i>n</i>-Butyl-3-(3-methylphenyl)-1<i>H</i>-1,2,4-triazol-5(4<i>H</i>)-one
C13H17N3O
Acta Crystallographica Section E (2008) 64, 8 o1388
a=16.905(5)Å b=18.139(5)Å c=8.145(2)Å
α=90.00° β=90.00° γ=90.00°
2-{2-[(2,6-Dichlorophenyl)amino]phenyl}ethanol
C14H13Cl2NO
Acta Crystallographica Section E (2011) 67, 2 o273
a=8.3521(3)Å b=15.0986(5)Å c=10.9225(5)Å
α=90° β=107.1800(10)° γ=90°
[2-(2,3-Dimethylanilino)phenyl]methanol
C15H17NO
Acta Crystallographica Section E (2010) 66, 9 o2373
a=26.819(2)Å b=5.0317(4)Å c=21.4156(15)Å
α=90° β=118.198(3)° γ=90°
(+)-rhododendrol
C10H14O2
Acta Crystallographica Section E (2011) 67, 4 o952
a=7.2342(2)Å b=6.3815(2)Å c=9.9419(4)Å
α=90.00° β=92.216(2)° γ=90.00°
<i>N</i>-Methylpyrrolidine-1-carbothioamide
C6H12N2S
Acta Crystallographica Section E (2012) 68, 6 o1706
a=8.616(2)Å b=9.077(2)Å c=10.796(3)Å
α=73.725(14)° β=86.656(15)° γ=76.177(16)°
<i>N</i>-(2,5-Dimethoxyphenyl)-6-nitroquinazolin-4-amine
C16H14N4O4
Acta Crystallographica Section E (2013) 69, 1 o8
a=7.2440(7)Å b=10.2832(10)Å c=11.1622(11)Å
α=72.475(2)° β=83.663(2)° γ=70.429(2)°
1,3-Bis(1-phenylethyl)imidazolidine-2-thione
C19H22N2S
Acta Crystallographica Section E (2012) 68, 4 o1188
a=5.8692(5)Å b=5.8692(5)Å c=50.637(5)Å
α=90.00° β=90.00° γ=90.00°
2-(6-Methoxynaphthalen-2-yl)-1-(morpholin-4-yl)propan-1-one
C18H21NO3
Acta Crystallographica Section E (2012) 68, 9 o2636
a=9.5947(15)Å b=6.6293(8)Å c=12.340(2)Å
α=90° β=92.221(5)° γ=90°
2-(4-Isobutylphenyl)-1-(morpholin-4-yl)propan-1-one
C17H25NO2
Acta Crystallographica Section E (2012) 68, 9 o2637
a=14.1389(19)Å b=10.3358(15)Å c=11.3552(15)Å
α=90° β=103.426(8)° γ=90°
2-(4-Methylphenyl)-2-oxoethyl 3-bromobenzoate
C16H13BrO3
Acta Crystallographica Section E (2012) 68, 12 o3465
a=4.7977(3)Å b=10.9951(7)Å c=14.1645(8)Å
α=74.829(5)° β=87.758(5)° γ=79.327(5)°